Modis Therapeutics lands $30 mln Series A
Oakland, California-based Modis Therapeutics, a developer of medicines for patients with rare genetic diseases, has raised $30 million in Series A funding. F-Prime Capital Partners and OrbiMed led the round.
1 October 2018•1 min read
